Keyphrases
Mode of Delivery
100%
Metformin
100%
Metabolic Benefits
100%
Anti-obesity
100%
Subcutaneous White Adipose Tissue
55%
Obesity
44%
Microneedles
44%
Transdermal Delivery
44%
Iontophoresis
44%
C57BL
22%
Oral Gavage
22%
White Adipose Tissue
11%
Local Delivery
11%
Inflammation
11%
Brown Adipose Tissue
11%
Public Health Risk
11%
High Efficacy
11%
Effective Approach
11%
Phosphorylation
11%
FDA-approved Drugs
11%
Oral Administration
11%
Metabolic Health
11%
Energy Metabolism
11%
Target Specificity
11%
Body Fat
11%
Obese Mice
11%
Metabolic Effects
11%
Local Injection
11%
Low Body Weight
11%
Pharmacotherapy
11%
Antidiabetic Drugs
11%
Renal Clearance
11%
Healthy Lifestyle Intervention
11%
AMP-activated Protein Kinase
11%
Low Oral Bioavailability
11%
Medicine and Dentistry
Glycon
100%
Subcutaneous White Adipose Tissue
44%
Transdermal Delivery
44%
Iontophoresis
44%
Feeding
22%
White Adipose Tissue
22%
Disease
11%
Healthy Lifestyle
11%
Public Health
11%
Drug Therapy
11%
Energy Metabolism
11%
Body Weight
11%
Side Effect
11%
Lifestyle Intervention
11%
Antidiabetic Agent
11%
Inguinal White Adipose Tissue
11%
Body Fat
11%
Bioavailability
11%
Oral Drug Administration
11%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
11%
Renal Clearance
11%
Pharmacology, Toxicology and Pharmaceutical Science
Metformin
100%
Transdermal Delivery
44%
Iontophoresis
44%
Mouse
11%
Inflammation
11%
Side Effect
11%
Disease
11%
Pharmacotherapy
11%
Bioavailability
11%
Antidiabetic Agent
11%
Mouse Mutant
11%
C57BL 6 Mouse
11%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
11%